These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19917055)

  • 1. The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells.
    Kajiyama H; Shibata K; Ino K; Mizutani S; Nawa A; Kikkawa F
    Cancer Sci; 2010 Feb; 101(2):347-54. PubMed ID: 19917055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase IV in tumor progression.
    Kikkawa F; Kajiyama H; Shibata K; Ino K; Nomura S; Mizutani S
    Biochim Biophys Acta; 2005 Aug; 1751(1):45-51. PubMed ID: 16054016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
    Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
    BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.
    Kikkawa F; Kajiyama H; Ino K; Shibata K; Mizutani S
    Int J Cancer; 2003 Jul; 105(6):779-83. PubMed ID: 12767062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma.
    Kajiyama H; Kikkawa F; Suzuki T; Shibata K; Ino K; Mizutani S
    Cancer Res; 2002 May; 62(10):2753-7. PubMed ID: 12019149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells.
    Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S
    Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.
    Craveiro V; Yang-Hartwich Y; Holmberg JC; Joo WD; Sumi NJ; Pizzonia J; Griffin B; Gill SK; Silasi DA; Azodi M; Rutherford T; Alvero AB; Mor G
    Cancer Med; 2013 Dec; 2(6):751-62. PubMed ID: 24403249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Ann N Y Acad Sci; 2006 Nov; 1086():233-40. PubMed ID: 17185520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
    Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
    Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis.
    Yang X; Zhang X; Wu R; Huang Q; Jiang Y; Qin J; Yao F; Jin G; Zhang Y
    Oncotarget; 2017 Jan; 8(5):8679-8692. PubMed ID: 28060721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.
    Aytac U; Sato K; Yamochi T; Yamochi T; Ohnuma K; Mills GB; Morimoto C; Dang NH
    Br J Cancer; 2003 Feb; 88(3):455-62. PubMed ID: 12569391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
    Kajiyama H; Shibata K; Terauchi M; Yamashita M; Ino K; Nawa A; Kikkawa F
    Int J Oncol; 2007 Aug; 31(2):277-83. PubMed ID: 17611683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD26/dipeptidyl peptidase IV and its role in cancer.
    Pro B; Dang NH
    Histol Histopathol; 2004 Oct; 19(4):1345-51. PubMed ID: 15375776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
    Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
    PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.
    Tsuji T; Sugahara K; Tsuruda K; Uemura A; Harasawa H; Hasegawa H; Hamaguchi Y; Tomonaga M; Yamada Y; Kamihira S
    Int J Hematol; 2004 Oct; 80(3):254-60. PubMed ID: 15540901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
    Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.
    Huang JM; Zhang GN; Shi Y; Zha X; Zhu Y; Wang MM; Lin Q; Wang W; Lu HY; Ma SQ; Cheng J; Deng BF
    Sci Rep; 2014 Jan; 4():3840. PubMed ID: 24452475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
    Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
    Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.